References
- Sowerwine KJ, Holland SM, Freeman AF. Hyper-IgE syndrome update. Ann NY Acad Sci 2012;1250:25–32.
- Grimbacher B, Holland SM, Gallin JI, et al. Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med 1999;340:692–702.
- Kumanovics A, Perkins SL, Gilbert H, et al. Diffuse large B cell lymphoma in hyper-IgE syndrome due to STAT3 mutation. J Clin Immunol 2010;30:886–893.
- Landgren O, Goedert JJ, Rabkin CS, et al. Circulating serum free light chains as predictive markers of AIDS-related lymphoma. J Clin Oncol 2010;28:773–779.
- Engels EA, Preiksaitis J, Zingone A, et al. Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder. Am J Transplant 2012;12:1268–1274.
- Hutchison CA, Landgren O. Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation. Clin Chem 2011;57:1387–1389.
- Bradwell AR, Carr-Smith HD, Mead GP, et al. Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine. Clin Chem 2001;47:673–680.
- Dispenzieri A, Katzmann JA, Kyle RA, et al. Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population. Mayo Clin Proc 2012;87:517–523.